The Radiotherapy Market size was estimated USD 6.79 billion in 2023 and is expected to reach USD 10.19 billion by 2031 at a CAGR of 5.53% during the forecast period of 2024-2031.
The main drivers of this market's expansion are the development of Radiotherapy technology and the growing prevalence of cancer. Other factors influencing the growth of this market include rising public awareness of the advantages of Radiotherapy and the use of particle therapy in the treatment of cancer. The lack of qualified oncologists and radiologists, as well as poor healthcare infrastructure, particularly in developing nations, limit the growth of this industry. Additional factors that are anticipated to impede the growth of this market during the projected period include the high cost of Radiotherapy devices and the high degree of complexity involved with radiotherapy treatment.
The demand for Radiotherapy has grown over the past several years as a result of both the rising global cancer incidence and the rising demand for radiotherapy. The American Cancer Society's 2022 report states that breast cancer is the most common disease, accounting for over 3.2 lakh and 51,500 fresh cases of aggressive and non-invasive breast tumours, respectively, in the United States. Additionally, during the course of the projection period, it is anticipated that increasing R&D will raise demand for radiotherapy.
DRIVERS
Attempts to raise awareness of the advantages of Radiotherapy.
The advantages of Radiotherapy treatments have motivated several activities, including conferences and symposia, in recent years. In these situations, there is a bigger focus on raising awareness of the advantages and therapeutic benefits of Radiotherapy as a treatment option for a variety of malignancies. To raise awareness and provide radiographers and oncologists with training for Radiotherapy operations, a number of radiotherapy-related events are being planned. Such activities are crucial in spreading knowledge about the advantages of the various Radiotherapy techniques, which is anticipated to increase demand for and uptake of radiotherapy devices.
RESTRAIN
A lack of qualified radiologists and oncologists.
OPPORTUNITY
Boosting public and private funding for cancer research.
CHALLENGES
Tumours are difficult to see during Radiotherapy operations.
The difficulty in identifying tumours and separating them from healthy, normal tissues during Radiotherapy operations is one of the biggest problems encountered. It is anticipated that developments in ionising Radiotherapy therapy for the treatment of cancer will aid in overcoming this obstacle. It becomes challenging to simply radiate the malignant expansion without damaging the surrounding tissues, though, because tumours can change their structure on a regular basis. Radiologists place a safety buffer around the tumour to reduce this. Additionally, it becomes imperative to restrict the Radiotherapy dosage range in order to minimise the harm to the surrounding healthy tissue, which raises the number of treatment cycles required to completely destroy tumorous cells. This is one of the main causes of the rising expense of cancer treatment for patients.
A significant humanitarian catastrophe for Europe was sparked by Russia's invasion of Ukraine on February 24, 2022, and a variety of healthcare facilities, including cancer care, was damaged or destroyed. In contrast to many other war-torn nations, the people of Ukraine had access to a relatively advanced cancer treatment system that included Radiotherapy. Prior to the conflict, 52 radiotherapy centres with around 107 Radiotherapy machines, 87 of which were the older cobalt machines, supplied radiotherapy over the majority of Ukraine. In comparison to the recommended 1 machine per 100,000 people, this amounted to about 1 machine every 500,000 people. Prior to the conflict, the Ministry of Health planned to upgrade by switching from its primarily outdated Cobalt machines to more contemporary and flexible equipment the linear accelerators. There were strong linkages between the Ukrainian Radiotherapy communities in the West and the Ukrainian Association of Medical Physics.
IMPACT OF ONGOING RECESSION
Financial Stress on Healthcare Providers During a recession, healthcare institutions may have financial difficulties that force them to delay budget cuts, personnel reductions, or equipment improvements. The effectiveness and availability of Radiotherapy services may be impacted by this. Investment Effect The market for Radiotherapy depends on continual research and development, which needs funding from both the public and commercial sectors. Investment in medical technology and breakthroughs may decrease during a recession, which might have an impact on radiotherapy innovation. Potential Opportunities On the other hand, if certain Radiotherapy providers offer cost-effective treatments as opposed to more expensive treatment choices, they may experience a surge in demand during a recession. Radiotherapy is an option for those looking for less expensive medical care. Government policies and economic downturns might influence how healthcare is provided.
By Type
Product
Service
By Technology
External Beam Radiotherapy
Linear Accelerators
Conventional Linear Accelerators
Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
Gamma Knife
CyberKnife
TomoTherapy
Conventional Cobalt-60 Teletherapy Units
Particle Therapy Systems
Cyclotrons
Synchrotrons
Synchrocyclotron
Internal Beam Radiotherapy/Brachytherapy
Seeds
Afterloaders
Applicators
IORT Systems
Systemic Radiotherapy
lobenguane (I-131)
Samarium-153
Rhenium-186
Other Systemic Radiotherapy Products
By Application
External Beam Radiotherapy
Prostate Cancer
Breast Cancer
Lung Cancer
Head and Neck Cancer
Colorectal Cancer
Other Cancers
Internal Beam Radiotherapy/Brachytherapy
Prostate Cancer
Gynecological Cancer
Breast Cancer
Cervical Cancer
Penile Cancer
Other Cancers
By Procedure
External Beam Radiotherapy
Image-guided Radiotherapy
Intensity-modulated Radiotherapy
Stereotactic Therapy
Particle Therapy
3D Conformal Radiotherapy
Internal Beam Radiotherapy/Brachytherapy
High-dose-rate Brachytherapy
Low-dose-rate Brachytherapy
Pulsed-dose-rate Brachytherapy
Systemic Radiotherapy
Intravenous Radiotherapy
Oral Radiotherapy
Instillation Radiotherapy
By End User
Hospitals
Independent Radiotherapy Centers.
.png)
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSES
From 2022 to 2031, North America is anticipated to hold a sizable portion of the worldwide Radiotherapy treatment market. During the projection period, it is predicted that rising health care spending, new product approvals, an increase in mergers and acquisitions, and an increase in cancer incidence will boost the Radiotherapy therapy market in the area. The CDC estimates that every year there will be a rise in the overall number of new cases of cancer in the United States of around 20–22% for women and 24% for men.
The market in Europe is expected to be driven by an increase in R&D efforts, the availability of more effective and precise cancer therapies, and manufacturer partnerships throughout the projected period. Germany's market is anticipated to grow rapidly between 2022 and 2031. This is clear when medical professionals pay more attention to how patients are positioned during radiotherapy, a procedure that helps deliver more Radiotherapy to a patient in fewer sessions while also saving time and money.
The major Key players are Siemens Healthineers AG, Elekta, Accuray Incorporated, IBA, ViewRay Technologies, Inc, Hitachi Ltd, iCAD, inc, IsoRay, Inc, Mevioi Medical Systems, Inc, Panacea Medical Technologies Pvt. Ltd, P-cure Ltd, and ZEISS Group, and others.
Max Institute of Cancer Care (MICC): In February 2022, the 2nd generation synchronisation respiratory motion management system and Radixact X9 Tomotherapy were introduced by the Radiotherapy Oncology Department at the Max Institute of Cancer Care (MICC), Saket, India. In order to prevent the tumour from being missed by chest or abdominal breathing movement during Radiotherapy, this Radiotherapy therapy treatment for cancer patients uses Artificial Intelligence (Al)-based real-time tracking and treatment delivery.
Elekta: In April 2022, With the help of a global commercial collaboration agreement in the field of Radiotherapy oncology, Elekta, a pioneer of precision Radiotherapy therapy solutions, and GE Healthcare, a producer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures, are now able to offer hospitals a comprehensive offering across imaging and therapy for cancer patients who need Radiotherapy therapy.
| Report Attributes | Details |
| Market Size in 2023 | US$ 6.79 Bn |
| Market Size by 2031 | US$ 10.19 Bn |
| CAGR | CAGR of 5.53% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Product, Service) • By Technology (External Beam Radiotherapy, Internal Beam Radiotherapy/Brachytherapy, Systemic Radiotherapy) • By Application (External Beam Radiotherapy, Prostate Cancer, Breast Cancer, Lung Cancer) • By Procedure (Image-guided Radiotherapy, Intensity-modulated Radiotherapy) • By End User (Hospitals, Independent Radiotherapy Centers) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Siemens Healthineers AG, Elekta, Accuray Incorporated, IBA, ViewRay Technologies, Inc, Hitachi Ltd, iCAD, inc, IsoRay, Inc, Mevioi Medical Systems, Inc, Panacea Medical Technologies Pvt. Ltd, P-cure Ltd, and ZEISS Group |
| Key Drivers | • Attempts to raise awareness of the advantages of Radiotherapy. |
| Market Restraints | • A lack of qualified radiologists and oncologists. |
Ans: The Radiotherapy Market is expected to grow at 5.4% CAGR from 2023 to 2030.
Ans: According to our analysis, the Radiotherapy Market is anticipated to reach USD 9.44 billion by 2030.
Ans: The prominent players in the Radiotherapy Siemens Healthineers AG, Elekta, Accuray Incorporated, IBA, ViewRay Technologies, Inc, Hitachi Ltd, iCAD, Inc.
Ans: In terms of type, the external beam radiotherapy market was dominant in 2022.
Ans: Yes, you may request customization based on your company's needs.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Radiotherapy Market, By Type
8.1 Product
8.2 Service
9. Radiotherapy Market, By Technology
9.1 External Beam Radiotherapy
9.1.1 Linear Accelerators
9.1.2 Conventional Cobalt-60 Teletherapy Units
9.1.3 Particle Therapy Systems
9.2 Internal Beam Radiotherapy/Brachytherapy
9.2.1 Seeds
9.2.2 Afterloaders
9.2.3 Applicators
9.2.4 IORT Systems
9.3 Systemic Radiotherapy
9.3.1 lobenguane (I-131)
9.3.2 Samarium-153
9.3.3 Rhenium-186
9.3.4 Other Systemic Radiotherapy Products
10. Radiotherapy Market, By Application
10.1 External Beam Radiotherapy
10.1.1 Prostate Cancer
10.1.2 Breast Cancer
10.1.3 Lung Cancer
10.1.4 Head and Neck Cancer
10.1.5 Colorectal Cancer
10.1.6 Other Cancers
10.2 Internal Beam Radiotherapy/Brachytherapy
10.2.1 Prostate Cancer
10.2.2 Gynecological Cancer
10.2.3 Breast Cancer
10.2.4 Cervical Cancer
10.2.5 Penile Cancer
10.2.6 Other Cancers
11. Radiotherapy Market, By Procedure
11.1 External Beam Radiotherapy
11.1.1 Image-guided Radiotherapy
11.1.2 Intensity-modulated Radiotherapy
11.2.3 Stereotactic Therapy
11.2.4 Particle Therapy
11.2.5 3D Conformal Radiotherapy
11.2 Internal Beam Radiotherapy/Brachytherapy
11.2.1 High-dose-rate Brachytherapy
11.2.2 Low-dose-rate Brachytherapy
11.2.3 Pulsed-dose-rate Brachytherapy
11.2.4 Systemic Radiotherapy
11.2.5 Intravenous Radiotherapy
11.2.6 Oral Radiotherapy
11.2.7Instillation Radiotherapy
12. Radiotherapy Market, By End User
12.1 Hospitals
12.2 Independent Radiotherapy Centers
13 Regional Analysis
13.1 Introduction
13.2 North America
13.2.1 North America Radiotherapy Market By Country
13.2.2 North America Radiotherapy Market By Type
13.2.3 North America Radiotherapy Market By Technology
13.2.4 North America Radiotherapy Market By Application
13.2.5 North America Radiotherapy Market By Procedure
13.2.6 North America Radiotherapy Market By End-use
13.2.7 USA
13.2.7.1 USA Radiotherapy Market By Type
13.2.7.2 USA Radiotherapy Market By Technology
13.2.7.3 USA Radiotherapy Market By Application
13.2.7.4 USA Radiotherapy Market By Procedure
13.2.7.5 USA Radiotherapy Market By End-use
13.2.8 Canada
13.2.8.1 Canada Radiotherapy Market By Type
13.2.8.2 Canada Radiotherapy Market By Technology
13.2.8.3 Canada Radiotherapy Market By Application
13.2.8.4 Canada Radiotherapy Market By Procedure
13.2.8.5 Canada Radiotherapy Market By End-use
13.2.9 Mexico
13.2.9.1 Mexico Radiotherapy Market By Type
13.2.9.2 Mexico Radiotherapy Market By Technology
13.2.9.3 Mexico Radiotherapy Market By Application
13.2.9.4 Mexico Radiotherapy Market By Procedure
13.2.9.5 Mexico Radiotherapy Market By End-use
13.3 Europe
13.3.1 Eastern Europe
13.3.1.1 Eastern Europe Radiotherapy Market By Country
13.3.1.2 Eastern Europe Radiotherapy Market By Type
13.3.1.3 Eastern Europe Radiotherapy Market By Technology
13.3.1.4 Eastern Europe Radiotherapy Market By Application
13.3.1.5 Eastern Europe Radiotherapy Market By Procedure
13.3.1.6 Eastern Europe Radiotherapy Market By End-use
13.3.1.7 Poland
13.3.1.7.1 Poland Radiotherapy Market By Type
13.3.1.7.2 Poland Radiotherapy Market By Technology
13.3.1.7.3 Poland Radiotherapy Market By Application
13.3.1.7.4 Poland Radiotherapy Market By Procedure
13.3.1.7.5 Poland Radiotherapy Market By End-use
13.3.1.8 Romania
13.3.1.8.1 Romania Radiotherapy Market By Type
13.3.1.8.2 Romania Radiotherapy Market By Technology
13.3.1.8.3 Romania Radiotherapy Market By Application
13.3.1.8.4 Romania Radiotherapy Market By Procedure
13.3.1.8.5 Romania Radiotherapy Market By End-use
13.3.1.9 Hungary
13.3.1.9.1 Hungary Radiotherapy Market By Type
13.3.1.9.2 Hungary Radiotherapy Market By Technology
13.3.1.9.3 Hungary Radiotherapy Market By Application
13.3.1.9.4 Hungary Radiotherapy Market By Procedure
13.3.1.9.5 Hungary Radiotherapy Market By End-use
13.3.1.10 Turkey
13.3.1.10.1 Turkey Radiotherapy Market By Type
13.3.1.10.2 Turkey Radiotherapy Market By Technology
13.3.1.10.3 Turkey Radiotherapy Market By Application
13.3.1.10.4 Turkey Radiotherapy Market By Procedure
13.3.1.10.5 Turkey Radiotherapy Market By End-use
13.3.1.11 Rest of Eastern Europe
13.3.1.11.1 Rest of Eastern Europe Radiotherapy Market By Type
13.3.1.11.2 Rest of Eastern Europe Radiotherapy Market By Technology
13.3.1.11.3 Rest of Eastern Europe Radiotherapy Market By Application
13.3.1.11.4 Rest of Eastern Europe Radiotherapy Market By Procedure
13.3.1.11.5 Rest of Eastern Europe Radiotherapy Market By End-use
13.3.2 Western Europe
13.3.2.1 Western Europe Radiotherapy Market By Country
13.3.2.2 Western Europe Radiotherapy Market By Type
13.3.2.3 Western Europe Radiotherapy Market By Technology
13.3.2.4 Western Europe Radiotherapy Market By Application
13.3.2.5 Western Europe Radiotherapy Market By Procedure
13.3.2.6 Western Europe Radiotherapy Market By End-use
13.3.2.7 Germany
13.3.2.7.1 Germany Radiotherapy Market By Type
13.3.2.7.2 Germany Radiotherapy Market By Technology
13.3.2.7.3 Germany Radiotherapy Market By Application
13.3.2.7.4 Germany Radiotherapy Market By Procedure
13.3.2.7.5 Germany Radiotherapy Market By End-use
13.3.2.8 France
13.3.2.8.1 France Radiotherapy Market By Type
13.3.2.8.2 France Radiotherapy Market By Technology
13.3.2.8.3 France Radiotherapy Market By Application
13.3.2.8.4 France Radiotherapy Market By Procedure
13.3.2.8.5 France Radiotherapy Market By End-use
13.3.2.9 UK
13.3.2.9.1 UK Radiotherapy Market By Type
13.3.2.9.2 UK Radiotherapy Market By Technology
13.3.2.9.3 UK Radiotherapy Market By Application
13.3.2.9.4 UK Radiotherapy Market By Procedure
13.3.2.9.5 UK Radiotherapy Market By End-use
13.3.2.10 Italy
13.3.2.10.1 Italy Radiotherapy Market By Type
13.3.2.10.2 Italy Radiotherapy Market By Technology
13.3.2.10.3 Italy Radiotherapy Market By Application
13.3.2.10.4 Italy Radiotherapy Market By Procedure
13.3.2.10.5 Italy Radiotherapy Market By End-use
13.3.2.11 Spain
13.3.2.11.1 Spain Radiotherapy Market By Type
13.3.2.11.2 Spain Radiotherapy Market By Technology
13.3.2.11.3 Spain Radiotherapy Market By Application
13.3.2.11.4 Spain Radiotherapy Market By Procedure
13.3.2.11.5 Spain Radiotherapy Market By End-use
13.3.2.12 The Netherlands
13.3.2.12.1 Netherlands Radiotherapy Market By Type
13.3.2.12.2 Netherlands Radiotherapy Market By Technology
13.3.2.12.3 Netherlands Radiotherapy Market By Application
13.3.2.12.4 Netherlands Radiotherapy Market By Procedure
13.3.2.12.5 Netherlands Radiotherapy Market By End-use
13.3.2.13 Switzerland
13.3.2.13.1 Switzerland Radiotherapy Market By Type
13.3.2.13.2 Switzerland Radiotherapy Market By Technology
13.3.2.13.3 Switzerland Radiotherapy Market By Application
13.3.2.13.4 Switzerland Radiotherapy Market By Procedure
13.3.2.13.5 Switzerland Radiotherapy Market By End-use
13.3.2.14 Austria
13.3.2.14.1 Austria Radiotherapy Market By Type
13.3.2.14.2 Austria Radiotherapy Market By Technology
13.3.2.14.3 Austria Radiotherapy Market By Application
13.3.2.14.4 Austria Radiotherapy Market By Procedure
13.3.2.14.5 Austria Radiotherapy Market By End-use
13.3.2.15 Rest of Western Europe
13.3.2.15.1 Rest of Western Europe Radiotherapy Market By Type
13.3.2.15.2 Rest of Western Europe Radiotherapy Market By Technology
13.3.2.15.3 Rest of Western Europe Radiotherapy Market By Application
13.3.2.15.4 Rest of Western Europe Radiotherapy Market By Procedure
13.3.2.15.5 Rest of Western Europe Radiotherapy Market By End-use
13.4 Asia-Pacific
13.4.1 Asia Pacific Radiotherapy Market By Country
13.4.2 Asia Pacific Radiotherapy Market By Type
13.4.3 Asia Pacific Radiotherapy Market By Technology
13.4.4 Asia Pacific Radiotherapy Market By Application
13.4.5 Asia Pacific Radiotherapy Market By Procedure
13.4.6 Asia Pacific Radiotherapy Market By End-use
13.4.7 China
13.4.7.1 China Radiotherapy Market By Type
13.4.7.2 China Radiotherapy Market By Technology
13.4.7.3 China Radiotherapy Market By Application
13.4.7.4 China Radiotherapy Market By Procedure
13.4.7.5 China Radiotherapy Market By End-use
13.4.8 India
13.4.8.1 India Radiotherapy Market By Type
13.4.8.2 India Radiotherapy Market By Technology
13.4.8.3 India Radiotherapy Market By Application
13.4.8.4 India Radiotherapy Market By Procedure
13.4.8.5 India Radiotherapy Market By End-use
13.4.9 Japan
13.4.9.1 Japan Radiotherapy Market By Type
13.4.9.2 Japan Radiotherapy Market By Technology
13.4.9.3 Japan Radiotherapy Market By Application
13.4.9.4 Japan Radiotherapy Market By Procedure
13.4.9.5 Japan Radiotherapy Market By End-use
13.4.10 South Korea
13.4.10.1 South Korea Radiotherapy Market By Type
13.4.10.2 South Korea Radiotherapy Market By Technology
13.4.10.3 South Korea Radiotherapy Market By Application
13.4.10.4 South Korea Radiotherapy Market By Procedure
13.4.10.5 South Korea Radiotherapy Market By End-use
13.4.11 Vietnam
13.4.11.1 Vietnam Radiotherapy Market By Type
13.4.11.2 Vietnam Radiotherapy Market By Technology
13.4.11.3 Vietnam Radiotherapy Market By Application
13.4.11.4 Vietnam Radiotherapy Market By Procedure
13.4.11.5 Vietnam Radiotherapy Market By End-use
13.4.12 Singapore
13.4.12.1 Singapore Radiotherapy Market By Type
13.4.12.2 Singapore Radiotherapy Market By Technology
13.4.12.3 Singapore Radiotherapy Market By Application
13.4.12.4 Singapore Radiotherapy Market By Procedure
13.4.12.5 Singapore Radiotherapy Market By End-use
13.4.13 Australia
13.4.13.1 Australia Radiotherapy Market By Type
13.4.13.2 Australia Radiotherapy Market By Technology
13.4.13.3 Australia Radiotherapy Market By Application
13.4.13.4 Australia Radiotherapy Market By Procedure
13.4.13.5 Australia Radiotherapy Market By End-use
13.4.14 Rest of Asia-Pacific
13.4.14.1 APAC Radiotherapy Market By Type
13.4.14.2 APAC Radiotherapy Market By Technology
13.4.14.3 APAC Radiotherapy Market By Application
13.4.14.4 APAC Radiotherapy Market By Procedure
13.4.14.5 APAC Radiotherapy Market By End-use
13.5 The Middle East & Africa
13.5.1 Middle East
13.5.1.1 Middle East Radiotherapy Market By country
13.5.1.2 Middle East Radiotherapy Market By Type
13.5.1.3 Middle East Radiotherapy Market By Technology
13.5.1.4 Middle East Radiotherapy Market By Application
13.5.1.5 Middle East Radiotherapy Market By Procedure
13.5.1.6 Middle East Radiotherapy Market By End-use
13.5.1.7 UAE
13.5.1.7.1 UAE Radiotherapy Market By Type
13.5.1.7.2 UAE Radiotherapy Market By Technology
13.5.1.7.3 UAE Radiotherapy Market By Application
13.5.1.7.4 UAE Radiotherapy Market By Procedure
13.5.1.7.5 UAE Radiotherapy Market By End-use
13.5.1.8 Egypt
13.5.1.8.1 Egypt Radiotherapy Market By Type
13.5.1.8.2 Egypt Radiotherapy Market By Technology
13.5.1.8.3 Egypt Radiotherapy Market By Application
13.5.1.8.4 Egypt Radiotherapy Market By Procedure
13.5.1.8.5 Egypt Radiotherapy Market By End-use
13.5.1.9 Saudi Arabia
13.5.1.9.1 Saudi Arabia Radiotherapy Market By Type
13.5.1.9.2 Saudi Arabia Radiotherapy Market By Technology
13.5.1.9.3 Saudi Arabia Radiotherapy Market By Application
13.5.1.9.4 Saudi Arabia Radiotherapy Market By Procedure
13.5.1.9.5 Saudi Arabia Radiotherapy Market By End-use
13.5.1.10 Qatar
13.5.1.10.1 Qatar Radiotherapy Market By Type
13.5.1.10.2 Qatar Radiotherapy Market By Technology
13.5.1.10.3 Qatar Radiotherapy Market By Application
13.5.1.10.4 Qatar Radiotherapy Market By Procedure
13.5.1.10.5 Qatar Radiotherapy Market By End-use
13.5.1.11 Rest of Middle East
13.5.1.11.1 Rest of Middle East Radiotherapy Market By Type
13.5.1.11.2 Rest of Middle East Radiotherapy Market By Technology
13.5.1.11.3 Rest of Middle East Radiotherapy Market By Application
13.5.1.11.4 Rest of Middle East Radiotherapy Market By Procedure
13.5.1.11.5 Rest of Middle East Radiotherapy Market By End-use
13.5.2 Africa
13.5.2.1 Africa Radiotherapy Market By Country
13.5.2.2 Africa Radiotherapy Market By Type
13.5.2.3 Africa Radiotherapy Market By Technology
13.5.2.4 Africa Radiotherapy Market By Application
13.5.2.5 Africa Radiotherapy Market By Procedure
13.5.2.6 Africa Radiotherapy Market By End-use
13.5.2.7 Nigeria
13.5.2.7.1 Nigeria Radiotherapy Market By Type
13.5.2.7.2 Nigeria Radiotherapy Market By Technology
13.5.2.7.3 Nigeria Radiotherapy Market By Application
13.5.2.7.4 Nigeria Radiotherapy Market By Procedure
13.5.2.7.5 Nigeria Radiotherapy Market By End-use
13.5.2.8 South Africa
13.5.2.8.1 South Africa Radiotherapy Market By Type
13.5.2.8.2 South Africa Radiotherapy Market By Technology
13.5.2.8.3 South Africa Radiotherapy Market By Application
13.5.2.8.4 South Africa Radiotherapy Market By Procedure
13.5.2.8.5 South Africa Radiotherapy Market By End-use
13.5.2.9 Rest of Africa
13.5.2.9.1 Rest of Africa Radiotherapy Market By Type
13.5.2.9.2 Rest of Africa Radiotherapy Market By Technology
13.5.2.9.3 Rest of Africa Radiotherapy Market By Application
13.5.2.9.4 Rest of Africa Radiotherapy Market By Procedure
13.5.2.9.5 Rest of Africa Radiotherapy Market By End-use
13.6 Latin America
13.6.1 Latin America Radiotherapy Market By Country
13.6.2 Latin America Radiotherapy Market By Type
13.6.3 Latin America Radiotherapy Market By Technology
13.6.4 Latin America Radiotherapy Market By Application
13.6.5 Latin America Radiotherapy Market By Procedure
13.6.6 Latin America Radiotherapy Market By End-use
13.6.7 Brazil
13.6.7.1 Brazil Radiotherapy Market By Type
13.6.7.2 Brazil Radiotherapy Market By Technology
13.6.7.3Brazil Radiotherapy Market By Application
13.6.7.4 Brazil Radiotherapy Market By Procedure
13.6.7.5 Brazil Radiotherapy Market By End-use
13.6.8 Argentina
13.6.8.1 Argentina Radiotherapy Market By Type
13.6.8.2 Argentina Radiotherapy Market By Technology
13.6.8.3 Argentina Radiotherapy Market By Application
13.6.8.4 Argentina Radiotherapy Market By Procedure
13.6.8.5 Argentina Radiotherapy Market By End-use
13.6.9 Colombia
13.6.9.1 Colombia Radiotherapy Market By Type
13.6.9.2 Colombia Radiotherapy Market By Technology
13.6.9.3 Colombia Radiotherapy Market By Application
13.6.9.4 Colombia Radiotherapy Market By Procedure
13.6.9.5 Colombia Radiotherapy Market By End-use
13.6.10 Rest of Latin America
13.6.10.1 Rest of Latin America Radiotherapy Market By Type
13.6.10.2 Rest of Latin America Radiotherapy Market By Technology
13.6.10.3 Rest of Latin America Radiotherapy Market By Application
13.6.10.4 Rest of Latin America Radiotherapy Market By Procedure
13.6.10.5 Rest of Latin America Radiotherapy Market By End-use
14 Company Profile
14.1 Siemens Healthineers AG.
14.1.1 Company Overview
14.1.2 Financials
14.1.3 Product/Services/Offerings
14.1.4 SWOT Analysis
14.1.5 The SNS View
14.2 Elekta.
14.2.1 Company Overview
14.2.2 Financials
14.2.3 Product/Services/Offerings
14.2.4 SWOT Analysis
14.2.5 The SNS View
14.3 Accuray Incorporated.
14.3.1 Company Overview
14.3.2 Financials
14.3.3 Product/Services/Offerings
14.3.4 SWOT Analysis
14.3.5 The SNS View
14.4 IBA.
14.4.1 Company Overview
14.4.2 Financials
14.4.3 Product/Services/Offerings
14.4.4 SWOT Analysis
14.4.5 The SNS View
14.5 ViewRay Technologies, Inc.
14.5.1 Company Overview
14.5.2 Financials
14.5.3 Product/Services/Offerings
14.5.4 SWOT Analysis
14.5.5 The SNS View
14.6 Hitachi Ltd.
14.6.1 Company Overview
14.6.2 Financials
14.6.3 Product/Services/Offerings
14.6.4 SWOT Analysis
14.6.5 The SNS View
14.7 iCAD, Inc.
14.7.1 Company Overview
14.7.2 Financials
14.7.3 Product/Services/Offerings
14.7.4 SWOT Analysis
14.7.5 The SNS View
14.8 IsoRay, Inc.
14.8.1 Company Overview
14.8.2 Financials
14.8.3 Product/Services/Offerings
14.8.4 SWOT Analysis
14.8.5 The SNS View
14.9 Mevioi Medical Systems, Inc.
14.9.1 Company Overview
14.9.2 Financials
14.9.3 Product/Services/Offerings
14.9.4 SWOT Analysis
14.9.5 The SNS View
14.10 Panacea Medical Technologies Pvt. Ltd.
14.10.1 Company Overview
14.10.2 Financials
14.10.3 Product/Services/Offerings
14.10.4 SWOT Analysis
14.10.5 The SNS View
15. Competitive Landscape
15.1 Competitive Benchmarking
15.2 Market Share Analysis
15.3 Recent Developments
15.3.1 Industry News
15.3.2 Company News
15.3.3 Mergers & Acquisitions
16. USE Cases and Best Practices
17. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Dual Chamber Prefilled Syringes Market size was USD 154.21 million in 2022 and is expected to Reach USD 268.56 million by 2030 and grow at a CAGR of 7.08 % over the forecast period of 2023-2030.
The Non-Invasive Fat Reduction Market Size was valued at USD 1.57 billion in 2022 and is expected to reach USD 5.33 billion by 2030, and grow at a CAGR of 16.5% over the forecast period 2023-2030.
The Ureteroscope Market size was USD 832.74 Million in 2022 and is expected to Reach USD 1297.50 Million by 2030 and grow at a CAGR of 5.7% over the forecast period of 2023-2030.
The Topical Drug Delivery Market Size was valued at USD 225.73 billion in 2022 and is expected to reach USD 449.79 billion by 2030 and grow at a CAGR of 9% over the forecast period 2023-2030.
The mRNA Therapeutics Market size was valued at USD 40.06 billion in 2023 and is expected to grow at USD 45.85 billion by 2031, and grow at a CAGR of 1.7 % over the forecast period of 2024-2031.
The Behavioral Health Market size was valued at USD 151 billion in 2022 and is expected to reach USD 226.5 billion by 2030 and expand at a CAGR of 5.2 % during the forecast period.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
